{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:48:11Z","timestamp":1792986491028,"version":"4.5.0"},"reference-count":115,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>West Nile encephalitis emerged in 1999 in the United States, then rapidly spread through the North American continent causing severe disease in human and horses. Since then, outbreaks appeared in Europe, and in 2012, the United States experienced a new severe outbreak reporting a total of 5,387 cases of West Nile virus (WNV) disease in humans, including 243 deaths. So far, no human vaccine is available to control new WNV outbreaks and to avoid worldwide spreading. In this review, we discuss the state-of-the-art of West Nile vaccine development and the potential of a novel safe and effective approach based on recombinant live attenuated measles virus (MV) vaccine. MV vaccine is a live attenuated negative-stranded RNA virus proven as one of the safest, most stable and effective human vaccines. We previously described a vector derived from the Schwarz MV vaccine strain that stably expresses antigens from emerging arboviruses, such as dengue, West Nile or chikungunya viruses, and is strongly immunogenic in animal models, even in the presence of MV pre-existing immunity. A single administration of a recombinant MV vaccine expressing the secreted form of WNV envelope glycoprotein elicited protective immunity in mice and non-human primates as early as two weeks after immunization, indicating its potential as a human vaccine.<\/jats:p>","DOI":"10.3390\/v5102384","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T12:22:30Z","timestamp":1380543750000},"page":"2384-2409","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Vaccines in Development against West Nile Virus"],"prefix":"10.3390","volume":"5","author":[{"given":"Samantha","family":"Brandler","sequence":"first","affiliation":[{"name":"Unit\u00e9 de G\u00e9nomique Virale et Vaccination, INSTITUT PASTEUR, 28 rue du Dr Roux, Paris 75015, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Tangy","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de G\u00e9nomique Virale et Vaccination, INSTITUT PASTEUR, 28 rue du Dr Roux, Paris 75015, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1940.s1-20.471","article-title":"A neurotropic virus isolated from the blood of a native of Uganda","volume":"20","author":"Smithburn","year":"1940","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10096-003-1085-1","article-title":"West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas","volume":"23","author":"Zeller","year":"2004","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3201\/eid0804.010217","article-title":"Introduction of West Nile virus in the Middle East by migrating white storks","volume":"8","author":"Malkinson","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1051\/vetres\/2010039","article-title":"West Nile virus and its emergence in the United States of America","volume":"41","author":"Murray","year":"2010","journal-title":"Veterinary research"},{"key":"ref_5","unstructured":"West Nile Virus (WNV) Human Infections Reported to ArboNET, by State, United States, 2012 (as of December 11, 2012). 2012 [cited 2012 21\u201302\u20132013]. Available online:http:\/\/www.cdc.gov\/ncidod\/dvbid\/westnile\/surv&controlCaseCount12_detailed.htm."},{"key":"ref_6","unstructured":"Prevention, European Center for Disease Control and Prevention (ECDC). Available online:http:\/\/ecdc.europa.eu\/en\/healthtopics\/west_nile_fever\/West-Nile-fever-maps\/Pages\/index.aspx."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biologicals.2009.01.002","article-title":"Transfusion-transmitted infectious diseases","volume":"37","author":"Allain","year":"2009","journal-title":"Biologicals: J. Int. Ass. of Biol. Stand."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1542\/peds.2006-2107","article-title":"Transmission of West Nile virus through human breast milk seems to be rare","volume":"119","author":"Hinckley","year":"2007","journal-title":"Pediatrics"},{"key":"ref_9","unstructured":"(2004). Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR, 53, 154\u2013157."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1863-2378.2008.01208.x","article-title":"The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses","volume":"56","author":"Mackenzie","year":"2009","journal-title":"Zoon. Publ. Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/viro.2002.1449","article-title":"Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East","volume":"298","author":"Lanciotti","year":"2002","journal-title":"Virology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1586\/eri.12.59","article-title":"West Nile virus infections in Greece: an update","volume":"10","author":"Papa","year":"2012","journal-title":"Expert Rev. of Anti-Infect. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3201\/eid1804.110771","article-title":"West Nile virus lineage 2 from blood donor, Greece","volume":"18","author":"Papa","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3201\/eid1102.041028","article-title":"Novel flavivirus or new lineage of West Nile virus, central Europe","volume":"11","author":"Bakonyi","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1099\/vir.0.82403-0","article-title":"West Nile virus isolates from India: evidence for a distinct genetic lineage","volume":"88","author":"Bondre","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(12)70278-8","article-title":"West Nile virus bites back","volume":"11","author":"Arnold","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/imt.10.93","article-title":"Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus","volume":"3","author":"Beasley","year":"2011","journal-title":"Immunotherapy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","article-title":"Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus","volume":"26","author":"Martina","year":"2008","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1086\/517613","article-title":"A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity","volume":"195","author":"McDonald","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1128\/JVI.01735-06","article-title":"Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes","volume":"80","author":"Kanai","year":"2006","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1128\/JVI.02574-08","article-title":"Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion","volume":"83","author":"Nayak","year":"2009","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/14760584.5.4.409","article-title":"Antibody-dependent enhancement and vaccine development","volume":"5","author":"Thomas","year":"2006","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00676.x","article-title":"The structural immunology of antibody protection against West Nile virus","volume":"225","author":"Diamond","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008","journal-title":"Cell host & microbe"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1128\/JVI.02298-12","article-title":"An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection","volume":"87","author":"White","year":"2013","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"Smith","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354","volume":"107","author":"Kaufmann","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/JVI.00286-09","article-title":"Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step","volume":"83","author":"Vogt","year":"2009","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_37","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.vetimm.2008.02.002","article-title":"A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse","volume":"123","author":"Minke","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1016\/j.vaccine.2005.02.020","article-title":"Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge","volume":"23","author":"Karaca","year":"2005","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/infdis\/jiq074","article-title":"Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination","volume":"203","author":"Smith","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.vaccine.2012.08.063","article-title":"Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults >\/= 50 years of age","volume":"30","author":"Dayan","year":"2012","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2006.06.008","article-title":"Chimeric West Nile\/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity","volume":"24","author":"Pletnev","year":"2006","journal-title":"Vaccine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1297-9716-43-16","article-title":"Recent progress in West Nile virus diagnosis and vaccination","volume":"43","author":"Ulbert","year":"2012","journal-title":"Vet. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/vbz.2005.5.1","article-title":"Infectivity of West Nile\/dengue chimeric viruses for West Nile and dengue mosquito vectors","volume":"5","author":"Hanley","year":"2005","journal-title":"Vector Borne Zoonotic. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/infdis\/jir054","article-title":"A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial","volume":"203","author":"Ledgerwood","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/523650","article-title":"A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial","volume":"196","author":"Martin","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.vaccine.2006.08.018","article-title":"Preparation and immunogenic properties of a recombinant West Nile subunit vaccine","volume":"25","author":"Lieberman","year":"2007","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1128\/CVI.00119-09","article-title":"Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys","volume":"16","author":"Lieberman","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.vaccine.2006.08.008","article-title":"Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis","volume":"25","author":"Watts","year":"2007","journal-title":"Vaccine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7589\/2011-12-363","article-title":"Vaccination of captive nene (Branta sandvicensis) against West Nile virus using a protein-based vaccine (WN-80E)","volume":"49","author":"Jarvi","year":"2013","journal-title":"J. Wildlife Dis."},{"key":"ref_53","unstructured":"database, N. c. t. clinicaltrials.gov"},{"key":"ref_54","unstructured":"Coller, B.-A., Weeks-Levy, C., and Ogata, S. (2012). RECOMBINANT SUBUNIT WEST NILE VIRUS VACCINE FOR PROTECTION OF HUMAN SUBJECTS. Patent application number: 20120141520."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.vaccine.2005.03.006","article-title":"A recombinant envelope protein vaccine against West Nile virus","volume":"23","author":"Ledizet","year":"2005","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.vaccine.2008.10.046","article-title":"A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells","volume":"27","author":"Bonafe","year":"2009","journal-title":"Vaccine"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1743-422X-9-132","article-title":"Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus","volume":"9","author":"Zhu","year":"2012","journal-title":"Virol. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.vaccine.2009.03.034","article-title":"Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy","volume":"27","author":"Demento","year":"2009","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.4049\/jimmunol.1000768","article-title":"TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis","volume":"185","author":"Demento","year":"2010","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2567.2010.03251.x","article-title":"Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge","volume":"130","author":"Landes","year":"2010","journal-title":"Immunology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1743-422X-7-146","article-title":"A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice","volume":"7","author":"Spohn","year":"2010","journal-title":"Virol. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1743-422X-10-129","article-title":"A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies","volume":"10","author":"Chua","year":"2013","journal-title":"Virol. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.micinf.2007.05.013","article-title":"Co-immunization with West Nile DNA and inactivated vaccines provides synergistic increases in their immunogenicities in mice","volume":"9","author":"Ishikawa","year":"2007","journal-title":"Microbes. Infect."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1016\/j.vaccine.2009.01.137","article-title":"Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII","volume":"27","author":"Ramanathan","year":"2009","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.virol.2004.11.022","article-title":"West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response","volume":"332","author":"Anwar","year":"2005","journal-title":"Virology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2006.07.038","article-title":"Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives","volume":"356","author":"Seregin","year":"2006","journal-title":"Virology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1073\/pnas.1834270100","article-title":"DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus","volume":"100","author":"Hall","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nbt1400","article-title":"Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus","volume":"26","author":"Chang","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1016\/j.vaccine.2009.07.016","article-title":"RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters","volume":"27","author":"Widman","year":"2009","journal-title":"Vaccine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.4269\/ajtmh.2010.09-0310","article-title":"Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection","volume":"82","author":"Widman","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1128\/JVI.00662-08","article-title":"Identification of mutated cyclization sequences that permit efficient replication of West Nile virus genomes: use in safer propagation of a novel vaccine candidate","volume":"82","author":"Suzuki","year":"2008","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0065-3527(08)00402-8","article-title":"Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses","volume":"72","author":"Widman","year":"2008","journal-title":"Adv. Virus Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.vaccine.2008.03.010","article-title":"Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis","volume":"26","author":"Ishikawa","year":"2008","journal-title":"Vaccine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2008.03.009","article-title":"Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system","volume":"26","author":"Widman","year":"2008","journal-title":"Vaccine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/CVI.00070-07","article-title":"Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses","volume":"14","author":"Luo","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2007.12.021","article-title":"Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine","volume":"374","author":"Lim","year":"2008","journal-title":"Virology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1016\/j.vaccine.2007.09.055","article-title":"Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine","volume":"25","author":"Samina","year":"2007","journal-title":"Vaccine"},{"key":"ref_82","first-page":"373","article-title":"Phylogeny and molecular epidemiology of West Nile and Kunjin viruses","volume":"267","author":"Scherret","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3201\/eid0704.017418","article-title":"The relationships between West Nile and Kunjin viruses","volume":"7","author":"Scherret","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4269\/ajtmh.2011.11-0165","article-title":"West nile virus (Kunjin subtype) disease in the northern territory of Australia--a case of encephalitis and review of all reported cases","volume":"85","author":"Gray","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/JVI.02903-12","article-title":"A Hydrogen Peroxide-Inactivated Virus Vaccine Elicits Humoral and Cellular Immunity and Protects against Lethal West Nile Virus Infection in Aged Mice","volume":"87","author":"Pinto","year":"2013","journal-title":"J. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1016\/j.vaccine.2010.02.092","article-title":"An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system","volume":"28","author":"Orlinger","year":"2010","journal-title":"Vaccine"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virusres.2006.12.009","article-title":"Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV)","volume":"125","author":"Rosas","year":"2007","journal-title":"Virus Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.vaccine.2008.11.087","article-title":"Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01","volume":"27","author":"Iyer","year":"2009","journal-title":"Vaccine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jgm.837","article-title":"A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus","volume":"8","author":"Iglesias","year":"2006","journal-title":"J. Gene Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e3973","DOI":"10.1371\/journal.pone.0003973","article-title":"Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine","volume":"3","author":"Coutant","year":"2008","journal-title":"PLoS ONE"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1128\/JVI.79.12.7300-7310.2005","article-title":"Chimeric dengue 2 PDK-53\/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus","volume":"79","author":"Huang","year":"2005","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2004.09.014","article-title":"An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development","volume":"330","author":"Yamshchikov","year":"2004","journal-title":"Virology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.vaccine.2009.10.112","article-title":"Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus","volume":"28","author":"Whiteman","year":"2010","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.vaccine.2008.08.064","article-title":"Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations","volume":"26","author":"Yu","year":"2008","journal-title":"Vaccine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2006.03.007","article-title":"A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice","volume":"349","author":"Wicker","year":"2006","journal-title":"Virology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1128\/JVI.80.5.2396-2404.2006","article-title":"A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha\/beta interferon induction and attenuates virus virulence in mice","volume":"80","author":"Liu","year":"2006","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1128\/JVI.77.21.11546-11554.2003","article-title":"A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice","volume":"77","author":"Combredet","year":"2003","journal-title":"J. Virol."},{"key":"ref_98","unstructured":"Tangy, F., Lucas, M., Navarro-Sanchez, E., Frenkiel, M., Combredet, C., and Despres, P. Chimeric poly peptides and their therapeutic use against a flaviviridae infection. (CA2549086), Filed 20-06-2006 and issued 20-12-2006."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/JVI.78.1.146-157.2004","article-title":"A Single Injection of Recombinant Measles Vaccines Expressing HIV-1 Clade B Envelope Glycoproteins Induces Neutralizing Antibodies and Cellular Immune Responses to HIV","volume":"78","author":"Lorin","year":"2004","journal-title":"J. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/426824","article-title":"Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis","volume":"191","author":"Combredet","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1371\/journal.pntd.0000096","article-title":"Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus","volume":"1","author":"Brandler","year":"2007","journal-title":"PLoS neglected tropical diseases"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/infdis\/jis328","article-title":"Measles vaccine expressing the secreted form of west nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of west nile virus infection","volume":"206","author":"Brandler","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Brandler, S., Ruffie, C., Combredet, C., Brault, J.B., Najburg, V., Prevost, M.C., Habel, A., Tauber, E., Despres, P., and Tangy, F. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus. Vaccine, 2013.","DOI":"10.1016\/j.vaccine.2013.05.086"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1016\/j.vaccine.2010.07.073","article-title":"Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses","volume":"28","author":"Brandler","year":"2010","journal-title":"Vaccine"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e50397","DOI":"10.1371\/journal.pone.0050397","article-title":"Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine","volume":"7","author":"Stebbings","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00210-012-0793-4","article-title":"Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques","volume":"385","author":"Lorin","year":"2012","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1440-1711.2003.01166.x","article-title":"Infection of mouse neurons by West Nile virus is modulated by the interferon-inducible 2\u2019-5\u2019 oligoadenylate synthetase 1b protein","volume":"81","author":"Lucas","year":"2003","journal-title":"Immun. Cell Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3201\/eid0911.030226","article-title":"West Nile virus infection in nonhuman primate breeding colony, concurrent with human epidemic, southern Louisiana","volume":"9","author":"Ratterree","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/381461","article-title":"Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection","volume":"189","author":"Ratterree","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Wertheimer, A.M., Uhrlaub, J.L., Hirsch, A., Medigeshi, G., Sprague, J., Legasse, A., Wilk, J., Wiley, C.A., Didier, P., Tesh, R.B., Murray, K.O., Axthelm, M.K., Wong, S.W., and Nikolich-Zugich, J. Immune response to the West Nile virus in aged non-human primates. PLoS ONE, 5, e15514.","DOI":"10.1371\/journal.pone.0015514"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01314128","article-title":"Study on West Nile virus persistence in monkeys","volume":"75","author":"Pogodina","year":"1983","journal-title":"Arch. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2006.06.033","article-title":"Baboon model for West Nile virus infection and vaccine evaluation","volume":"355","author":"Wolf","year":"2006","journal-title":"Virology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a120664","article-title":"Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers","volume":"84","author":"Nathanson","year":"1966","journal-title":"Am. J. Epidemiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00005072-195610000-00007","article-title":"Neuropathology of experimental West Nile virus infection in monkeys","volume":"15","author":"Manuelidis","year":"1956","journal-title":"J. Neuropath. Exp. Neur."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/5\/10\/2384\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:49:37Z","timestamp":1760219377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/5\/10\/2384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,30]]},"references-count":115,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10]]}},"alternative-id":["v5102384"],"URL":"https:\/\/doi.org\/10.3390\/v5102384","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,30]]}}}